DURHAM, N.C., MARCH 24, 2017 — Premier Research is launching a smartphone-based patient reported outcome system to replace the paper diaries used in many clinical trials. Premier Mobile ePRO will give sponsors and researchers more accurate and timely patient reported data while reducing the burden on trial participants.
“Any study is only as good as the data it generates, and the paper diaries that remain the predominant means of collecting patient outcomes often yield inaccurate or incomplete information,” said Bruce Bailey, Executive Director, Interactive Response Technologies, at Premier Research. “The interactive voice response systems used in some trials are likewise cumbersome and slow, compromising patient inputs and denying sponsors the high-quality data their research depends on.”
Premier Mobile ePRO allows patients to enter trial data easily and securely using their Android or Apple phones. It’s fast — daily reporting takes about two minutes — and sponsors have access to the data in real-time, bypassing the need to manually translate the information from hundreds or thousands of diaries.
The capability is available as part of a full-service offering from Premier, or as a standalone service, so sponsors can realize these benefits regardless of what CRO is running their trials.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.